Ozempic (semaglutide) is a GLP-1 receptor agonist with a one-week half-life, taking 45 weeks to clear from the body after the last injection
Importantly, visualizing gastric contents with ultrasound can facilitate clearer communication with patients and surgeonsoften leading to greater understanding and acceptance of clinical decisions compared to relying solely on guideline-based explanations
Recent studies shows that GLP-1 receptor agonists are effective adjuncts to metformin for managing type 2 diabetes mellitus, especially for patients aiming to prevent weight gain or hyperglycemia
Gradual Weight Loss Progress Unlike rapid weight loss programs, which can be challenging to maintain, weight loss injections support gradual progress, allowing your body to adjust naturally while minimizing potential side effects
Elevated estrogen levels can lead to various menstrual disorders, including oligomenorrhea (infrequent periods), amenorrhea (absence of periods), and heavy menstrual bleeding